Human heart mast cells: a definitive case of mast cell heterogeneity

International Archives of Allergy and Immunology
V PatellaG Marone

Abstract

Mast cells and their chemical mediators play a role in cardiac and systemic anaphilaxis. Perivascular and cardiac mast cells have been implicated in the pathogenesis of coronary artery spasm, atherosclerosis, myocardial ischemia, and cardiomyopathy. Despite this, nothing is known about the immunological and biochemical characteristics of the human heart mast cell (HHMC). We have isolated and partially purified HHMC and compared them with mast cells isolated from lung (HLMC) and skin (HSMC) tissues. Cross-linking of the high-affinity receptor for IgE (Fc epsilon RI) by a polyclonal anti-Fc epsilon antibody caused the release of preformed (histamine and tryptase) and de novo synthesized mediators [peptide leukotriene C4 (LTC4) and prostaglandin D2 (PGD2)]. The tryptase content of HHMC (19.4 +/- 1.5 micrograms/10(6) cells) was lower than HSMC (33.4 +/- 2.5 micrograms/10(6) cells) and higher than HLMC (10.6 +/- 1.9 micrograms/10(6) cells). Maximal stimulation of HHMC with anti-IgE led to the release of LTC4 (17.5 +/- 5.1 ng/10(6) mast cells) and PGD2 (17.8 +/- 5.0 ng/10(6) mast cells, whereas HSMC synthesized more PGD2 (65.0 +/- 6.8 ng/10(6) mast cells) and much less LTC4 (< 5 ng/10(6) cells). Recombinant human C5a anaphylatoxin an...Continue Reading

Citations

Dec 31, 2003·Journal of Neuroimmunology·Theoharis C Theoharides, David E Cochrane
Mar 19, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Femke J BijlsmaRoel A deWeger
Aug 26, 2010·Cardiovascular Research·Scott P LevickJoseph S Janicki
Jan 30, 1999·Annals of the Rheumatic Diseases·I Gotis-GrahamH P McNeil
Jul 12, 2011·Trends in Pharmacological Sciences·Theoharis C TheoharidesDimitrios Kalogeromitros
Apr 7, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Heather Francis, Cynthia J Meininger
May 12, 2007·Immunology and Allergy Clinics of North America·Simon G A Brown
Jan 17, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Michail AlevizosTheoharis C Theoharides
Nov 13, 2014·Anaesthesia·J Sheldon, B Philips
Jul 27, 2014·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Elaine Zayas Marcelino da SilvaConstance Oliver
Jun 17, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Manjeet Singh, Harjot K Saini
Jan 13, 2018·International Journal of Molecular Sciences·Scott P Levick, Alexander Widiapradja
Jun 26, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·B RoyerM Arock
Oct 4, 2018·Expert Opinion on Therapeutic Patents·Sarfaraz Ahmad, Carlos M Ferrario
Nov 1, 1996·Clinical Pharmacology and Therapeutics·M GrossmannB B Hoffman
Oct 11, 2005·American Journal of Physiology. Heart and Circulatory Physiology·János SzebeniRolf Bünger
Dec 29, 2006·Annals of the New York Academy of Sciences·Theoharis C Theoharides, Dimitrios Kalogeromitros
Jul 19, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Gregory L BrowerJoseph S Janicki
Jan 1, 2014·Allergo Journal International·Gianni MaroneFrancescopaolo Granata
Feb 13, 2018·Immunological Reviews·Gilda VarricchiBernhard F Gibbs
Jul 2, 2020·Trends in Immunology·Gilda VarricchiPetri T Kovanen
Oct 9, 2021·Heart Failure Reviews·Scott P Levick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.